Abstract
After injection of 111In-labelled DTPA-D-Phe1-octreotide, intraoperative tumour localisation was performed using a scintillation detector in 23 patients with neuroendocrine tumours. Count rates from suspect tumour lesions and adjacent normal tissue were expressed as a ratio before (Rin situ) and after (Rex vivo) excision. 111In activity concentration ratios of tumour tissue to blood (T/B) were determined in a gamma counter. In patients with midgut carcinoids, (all scintigraphy positive), false Rin situ recordings were found in 4/29 macroscopically identified tumours. T/B ratios were all high (27-650). In patients with medullary thyroid carcinomas (eight out of ten scintigraphy positive), misleading Rin situ results were found in 4/37 macroscopically identified tumours. T/B ratios were lower (3-39) than those seen in midgut carcinoids. Two out of four patients with endocrine pancreatic tumours had positive scintigraphy, reliable intraoperative measurements and very high T/B ratios (910-1500). One patient with a gastric carcinoid had correct measurements in situ and ex vivo with high T/B ratios (71-210). In situ measurements added little information to preoperative scintigraphy and surgical findings using the present detection system. Rex vivo measurements were more reliable. The very high T/B ratios seen in midgut carcinoids and some endocrine pancreatic tumours would be favourable for future radiation therapy via somatostatin receptors.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 24 print issues and online access
$259.00 per year
only $10.79 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Wangberg, B., Forssell-Aronsson, E., Tisell, LE. et al. Intraoperative detection of somatostatin-receptor-positive neuroendocrine tumours using indium-111-labelled DTPA-D-Phe1-octreotide. Br J Cancer 73, 770–775 (1996). https://doi.org/10.1038/bjc.1996.134
Issue Date:
DOI: https://doi.org/10.1038/bjc.1996.134
This article is cited by
-
Radioguided Surgery for Gastroenteropancreatic Neuroendocrine Tumours: a Systematic Literature Review
Journal of Gastrointestinal Surgery (2021)
-
Evaluation of two intraoperative gamma detectors for assessment of 177Lu activity concentration in vivo
EJNMMI Physics (2017)
-
Radioguided Exploration Facilitates Surgical Cytoreduction of Neuroendocrine Tumors
Journal of Gastrointestinal Surgery (2012)
-
Long‐term Survival of Patients with Small Intestinal Carcinoid Tumors
World Journal of Surgery (2004)
-
Receptor-targeted optical imaging of tumors with near-infrared fluorescent ligands
Nature Biotechnology (2001)